Semaglutide lowers body weight in rodents via distributed neural pathways

Mar 28, 2020JCI insight

Semaglutide lowers body weight in rodents through multiple brain systems

AI simplified

Abstract

Semaglutide induced weight loss and reduced food intake while maintaining energy expenditure.

  • Weight loss may be linked to changes in food preference and intake mediated by GLP-1 receptors in the brain.
  • Semaglutide accessed key brain regions involved in appetite regulation, including the brainstem and hypothalamus, without crossing the blood-brain barrier.
  • Activation of c-Fos was observed in 10 brain areas, indicating diverse neural pathways may be involved in its effects on food intake.
  • Upregulation of specific hormones and enzymes was noted in the area postrema following semaglutide treatment.
  • The interaction of semaglutide with various GLP-1 receptor populations could influence neural pathways related to food intake and energy management.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free